"路径跳跃":在黑色细胞瘤的发病过程中需要考虑的新分子现象
1Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain.
The American Journal of dermatopathology
|January 9, 2025
概括
这项研究揭示了黑色细胞瘤中的分子"途径跳跃",其中具有BRAF突变的常见 (路线I) 与缺乏这种突变的上皮质成分 (路线IV) 共同存在,这表明了新的瘤进展机制.
科学领域:
- 皮肤病理学 皮肤病理学
- 分子瘤学分子瘤学
- 癌症基因组学 癌症基因组学
背景情况:
- 目前的世卫组织分类确定了黑色细胞瘤的9种致病途径.
- 瘤被认为通过累积的突变从良性演变为恶性.
- 这项研究调查了从线性进展的潜在偏差.
研究的目的:
- 为了探索一个分子现象,建议一个分子现象.
- 跳跃就是跳跃,就是跳跃.
- 在黑色细胞瘤中,不同的致病途径之间.
- 为了分析两个连续的,形态上不同的群体的黑色素细胞瘤.
- 为了识别与这些独特的瘤组件相关的遗传突变.
主要方法:
- 选择两个具有双种群的黑色素细胞瘤 (神经和上皮状).
- 手动微解剖以分离不同的细胞群体.
- 免疫组织化学和分子研究,包括NRAS和BRAF突变的PCR.
主要成果:
- 在这两种瘤中,共同的神经元件 (路线I) 含有BRAF突变.
- 在这两种瘤中的上皮状元件 (IV路径) 都缺乏BRAF突变.
- 在任何瘤群体中没有检测到NRAS突变.
结论:
- 研究结果表明,在路线I和路线IV之间存在分子"路径跳跃"现象.
- 这种"途径跳跃"可能解释了"联合 nevi. "的分类.
- 这种现象可能被低估,因为诊断技术通常不采用微解剖.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


